Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Stabilization of TGF-β Receptor 1 by a Receptor-Associated Adaptor Dictates Feedback Activation of the TGF-β Signaling Pathway to Maintain Liver Cancer Stemness and Drug Resistance.

Kewei Liu | Fanxuan Tian | Xu Chen | Biyin Liu | Shuoran Tian | Yongying Hou | Lei Wang | Mengyi Han | Shiying Peng | Yuting Tan | Yuwei Pan | Zhaole Chu | Jinyang Li | Linrong Che | Dongfeng Chen | Liangzhi Wen | Zhongyi Qin | Xianfeng Li | Junyu Xiang | Xiu-Wu Bian | Qin Liu | Xiaoli Ye | Tao Wang | Bin Wang
Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

Dysregulation of the transforming growth factor-β (TGF-β) signaling pathway regulates cancer stem cells (CSCs) and drug sensitivity, whereas it remains largely unknown how feedback regulatory mechanisms are hijacked to fuel drug-resistant CSCs. Through a genome-wide CRISPR activation screen utilizing stem-like drug-resistant properties as a readout, the TGF-β receptor-associated binding protein 1 (TGFBRAP1) is identified as a TGF-β-inducible positive feedback regulator that governs sensitivity to tyrosine kinase inhibitors (TKIs) and promotes liver cancer stemness. By interacting with and stabilizing the TGF-β receptor type 1 (TGFBR1), TGFBRAP1 plays an important role in potentiating TGF-β signaling. Mechanistically, TGFBRAP1 competes with E3 ubiquitin ligases Smurf1/2 for binding to TGFΒR1, leading to impaired receptor poly-ubiquitination and proteasomal degradation. Moreover, hyperactive TGF-β signaling in turn up-regulates TGFBRAP1 expression in drug-resistant CSC-like cells, thereby constituting a previously uncharacterized feedback mechanism to amplify TGF-β signaling. As such, TGFBRAP1 expression is correlated with TGFΒR1 levels and TGF-β signaling activity in hepatocellular carcinoma (HCC) tissues, as well as overall survival and disease recurrence in multiple HCC cohorts. Therapeutically, blocking TGFBRAP1-mediated stabilization of TGFBR1 by selective inhibitors alleviates Regorafenib resistance via reducing CSCs. Collectively, targeting feedback machinery of TGF-β signaling pathway may be an actionable approach to mitigate drug resistance and liver cancer stemness.

Pubmed ID: 38981014

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: National Key Research and Development Program of China,
    Id: 2023YFC3402100
  • Agency: National Key Research and Development Program of China,
    Id: 2022YFA1105300
  • Agency: National Natural Science Foundation of China,
    Id: 81872027
  • Agency: National Natural Science Foundation of China,
    Id: 81822032
  • Agency: National Natural Science Foundation of China,
    Id: 91959111
  • Agency: National Natural Science Foundation of China,
    Id: 81902497
  • Agency: National Natural Science Foundation of China,
    Id: 82002582
  • Agency: National Natural Science Foundation of China,
    Id: 82303114
  • Agency: National Natural Science Foundation of China,
    Id: 82002585
  • Agency: National Natural Science Foundation of China,
    Id: 82170594
  • Agency: National Natural Science Foundation of China,
    Id: 81972305.
  • Agency: Natural Science Foundation of Chongqing,
    Id: CSTB2023NSCQ-LZX0156
  • Agency: Natural Science Foundation of Chongqing,
    Id: CSTC2019JCYJJQX0027
  • Agency: Natural Science Foundation of Chongqing,
    Id: CSTC2020JCYJ- MSXMX0171
  • Agency: Natural Science Foundation of Chongqing,
    Id: CSTB2024NSCQ-LZX0015
  • Agency: Natural Science Foundation of Chongqing,
    Id: CSTC2021JCYJ-MSXMX0340
  • Agency: Natural Science Foundation of Chongqing,
    Id: CSTC2020JCYJ-MSXMX0181
  • Agency: Army Medical University,
    Id: 2019CXLCA001
  • Agency: Army Medical University,
    Id: 2018XLC2023
  • Agency: Army Medical University,
    Id: 2019XQY19
  • Agency: the Key Laboratory of Tumor Immunopathology of Ministry of Education of China,
    Id: 2022JSZ807

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Addgene (tool)

RRID:SCR_002037

Non-profit plasmid repository dedicated to helping scientists around the world share high-quality plasmids. Facilitates archiving and distributing DNA-based research reagents and associated data to scientists worldwide. Repository contains over 65,000 plasmids, including special collections on CRISPR, fluorescent proteins, and ready-to-use viral preparations. There is no cost for scientists to deposit plasmids, which saves time and money associated with shipping plasmids themselves. All plasmids are fully sequenced for validation and sequencing data is openly available. We handle the appropriate Material Transfer Agreements (MTA) with institutions, facilitating open exchange and offering intellectual property and liability protection for depositing scientists. Furthermore, we curate free educational resources for the scientific community including a blog, eBooks, video protocols, and detailed molecular biology resources.

View all literature mentions

PeproTech (tool)

RRID:SCR_006802

An Antibody supplier

View all literature mentions

QIAGEN (tool)

RRID:SCR_008539

A commercial organization which provides assay technologies to isolate DNA, RNA, and proteins from any biological sample. Assay technologies are then used to make specific target biomolecules, such as the DNA of a specific virus, visible for subsequent analysis.

View all literature mentions

Millipore (tool)

RRID:SCR_008983

An Antibody supplier

View all literature mentions

Gene Expression Profiling Interactive Analysis (tool)

RRID:SCR_018294

Web server for cancer and normal gene expression profiling and interactive analyses. Interactive web server for analyzing RNA sequencing expression data of tumors and normal samples from TCGA and GTEx projects, using standard processing pipeline. Provides customizable functions such as tumor or normal differential expression analysis, profiling according to cancer types or pathological stages, patient survival analysis, similar gene detection, correlation analysis and dimensionality reduction analysis.

View all literature mentions

ELDA (tool)

RRID:SCR_018933

Software tool for limiting dilution analysis, with particular attention to needs of stem cell assays. Provides confidence intervals for all LDA data sets, including those with 0% or 100% responses. Other features include test of adequacy of single hit hypothesis, tests for frequency differences between multiple data sets, and ability to take advantage of cases where number of cells in sample is counted exactly.

View all literature mentions

BALB/cAnN-Foxn1nu/nu/Rj (tool)

RRID:IMSR_RJ:BALB-C-NUDE

Mus musculus with name BALB/cAnN-Foxn1nu/nu/Rj from IMSR.

View all literature mentions